首頁 > 市場調查報告書 > 醫療設備

體外診斷

C反應蛋白檢測市場規模、佔有率和成長分析（按檢測類型、檢測範圍、疾病領域、最終用途和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1898570

C反應蛋白檢測市場規模、佔有率和成長分析（按檢測類型、檢測範圍、疾病領域、最終用途和地區分類）－2026-2033年產業預測

C-reactive Protein Testing Market Size, Share, and Growth Analysis, By Assay Type (Immunoturbidimetric Assay, Elisa), By Detection Range (HS-CRP, Conventional CRP), By Disease Area, By End-Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 260 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，C 反應蛋白檢測市場規模將達到 31.9353 億美元，從 2025 年的 32.7017 億美元成長到 2033 年的 39.534 億美元，在預測期（2026-2033 年）內複合年成長率為 2.4%。

由於奈米技術的進步提高了現場疾病診斷的特異性、靈敏度和速度，C反應蛋白（CRP）檢測市場正經歷顯著成長。新開發的就地檢驗有望透過實現快速CRP檢測來推動市場需求成長。發炎性疾病、糖尿病和癌症發生率的上升，以及女性子宮內膜異位症等疾病盛行率的增加，也推動了這一趨勢。此外，診斷領域的投資增加和照護現場設備的日益普及預計也將促進市場擴張。隨著醫療保健系統尋求高效的診斷工具，CRP檢測市場有望實現強勁成長，因為它滿足了早期發現和監測各種健康狀況的需求。

C反應蛋白檢測市場促進因素

全球C反應蛋白檢測市場預計將迎來顯著成長，主要促進因素是心血管疾病盛行率的不斷上升以及旨在改進檢測方法的研究和開發投入的活性化。心血管疾病死亡率的驚人統計數據凸顯了這些疾病造成的大量死亡所帶來的嚴峻醫療保健挑戰。這種緊迫性凸顯了對精準診斷工具的需求，從而推動了對創新C反應蛋白檢測解決方案的進一步關注和投資。隨著醫療保健提供者和研究人員不斷認知到早期發現和監測與心臟疾病相關的發炎過程的重要性，對更先進檢測能力的需求預計將顯著增加。

限制C反應蛋白檢測市場的因素

全球C反應蛋白檢測市場的成長可能受到幾個關鍵因素的阻礙。主要因素是人們對C反應蛋白檢測的認知度較低，這可能會阻礙其普及和應用，尤其是在缺乏先進技術的中小經濟體中。此外，這些檢測方法的高成本，以及購買設備所需的大量初始投資，預計也將對市場擴張構成額外障礙。因此，這些挑戰可能會顯著限制C反應蛋白檢測市場在各地區的潛在發展。

C反應蛋白檢測市場趨勢

受以預防和管理慢性疾病為重點的宣傳活動日益增多的推動，C反應蛋白（CRP）檢測市場正呈現顯著的成長趨勢。政府主導的各項措施在提升CRP檢測的重要性方面發揮關鍵作用，尤其是在已開發國家，這些措施促進了CRP檢測在常規臨床實踐中的應用。 CRP檢測應用的持續普及證實了其在診斷和後續觀察發炎性疾病方面的價值，有助於改善患者的治療效果。隨著醫療服務提供者、患者和政策制定者逐漸認知到CRP檢測在預防性醫療保健管理中的重要性，該市場有望迎來強勁成長，並重塑全球診斷服務格局。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Thermo Fisher Scientific Inc.
Roche Diagnostics
Abbott Laboratories
Beckman Coulter
Bio-Rad Laboratories
Siemens Healthcare
Quest Diagnostics
Ortho Clinical Diagnostics
Randox Laboratories
Boditech Med Inc.
Merck Millipore
BioMerieux
Trinity Biotech
Becton, Dickinson and Company（BD）
Sekisui Diagnostics
Tosoh Bioscience Inc.
DiaSorin SpA
Fujifilm Corporation

結論與建議

簡介目錄

Product Code: SQMIG35A2715

C-reactive Protein Testing Market size was valued at USD 3193.53 Million in 2024 and is poised to grow from USD 3270.17 Million in 2025 to USD 3953.4 Million by 2033, growing at a CAGR of 2.4% during the forecast period (2026-2033).

The market for C-reactive protein (CRP) testing is experiencing significant growth driven by advancements in nanotechnology that enhance specificity, sensitivity, and speed for on-site disease diagnostics. Newly developed point-of-care assays are expected to boost demand as they enable rapid CRP testing. The rising incidence of inflammatory conditions, diabetes, and cancers further contributes to this trend, with an increasing prevalence of diseases like endometriosis among women. Additionally, heightened funding in the diagnostics sector and the growing adoption of point-of-care devices are anticipated to accelerate market expansion. As healthcare systems seek efficient and effective diagnostic tools, the CRP testing market is poised for robust growth, responding to the need for early detection and monitoring of various health conditions.

Top-down and bottom-up approaches were used to estimate and validate the size of the C-reactive Protein Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

C-reactive Protein Testing Market Segments Analysis

Global C-Reactive Protein Testing Market is segmented by assay type, detection range, disease area, end-use and region. Based on assay type, the market is segmented into immunoturbidimetric assay, ELISA, chemiluminescence immunoassay and others. Based on detection range, the market is segmented into HS-CRP, conventional CRP and cCRP. Based on disease area, the market is segmented into cardiovascular diseases, cancer, rheumatoid arthritis, inflammatory bowel disease, endometriosis, lupus and others. Based on end-use, the market is segmented into clinics, hospitals, laboratories, assisted living healthcare facilities, home and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the C-reactive Protein Testing Market

The global C-reactive protein testing market is poised for significant growth, primarily driven by the escalating prevalence of cardiovascular diseases and an upsurge in research and development efforts aimed at improving testing methodologies. The alarming statistics surrounding cardiovascular mortality highlight a critical healthcare concern, with numerous fatalities attributed to these conditions. This urgency underscores the need for accurate diagnostic tools, further fueling interest and investment in innovative C-reactive protein testing solutions. As healthcare providers and researchers continue to recognize the importance of early detection and monitoring of inflammatory processes related to heart disease, the demand for enhanced testing capabilities is expected to increase substantially.

Restraints in the C-reactive Protein Testing Market

The growth of the global C-reactive protein testing market is likely to be hindered by several significant factors. Chief among these is the limited awareness surrounding CRP testing, which could impede adoption and utilization, especially in low-to-medium-sized economies where access to advanced technologies is lacking. Furthermore, the prohibitive costs associated with these testing methods, coupled with the substantial initial investments needed for equipment setup, are expected to create additional barriers to market expansion. As a result, these challenges may significantly restrict the potential development of the C-reactive protein testing market in various regions.

Market Trends of the C-reactive Protein Testing Market

The C-reactive protein (CRP) testing market is witnessing a significant upward trend driven by heightened awareness campaigns focused on the prevention and management of chronic disorders. Government initiatives are playing a pivotal role in promoting the importance of CRP testing, consequently boosting its incorporation into routine clinical practices, particularly in developed countries. This increased adoption underscores the testing's value in diagnosing and monitoring inflammatory conditions, enhancing patient outcomes. As healthcare providers, patients, and policymakers recognize the critical role of CRP testing in proactive health management, the market is poised for robust growth, reshaping the landscape of diagnostic services globally.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Study Analysis

Global C-Reactive Protein Testing Market Size by Assay Type & CAGR (2026-2033)

Market Overview
Immunoturbidimetric Assay
Elisa
- Clinical
- Non-Clinical
Chemiluminescence Immunoassay
Others

Global C-Reactive Protein Testing Market Size by Detection Range & CAGR (2026-2033)

Market Overview
HS-CRP
Conventional CRP
CCRP

Global C-Reactive Protein Testing Market Size by Disease Area & CAGR (2026-2033)

Market Overview
Cardiovascular Diseases
Cancer
Rheumatoid Arthritis
Inflammatory Bowel Disease
Endometriosis
Lupus
Others

Global C-Reactive Protein Testing Market Size by End-Use & CAGR (2026-2033)

Market Overview
Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
Hospitals
- Urban Setting
- Rural Setting
Laboratories
- Urban Setting
- Rural Setting
Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
Home
Others

Global C-Reactive Protein Testing Market Size & CAGR (2026-2033)

North America (Assay Type, Detection Range, Disease Area, End-Use)
- US
- Canada
Europe (Assay Type, Detection Range, Disease Area, End-Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Assay Type, Detection Range, Disease Area, End-Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Assay Type, Detection Range, Disease Area, End-Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Assay Type, Detection Range, Disease Area, End-Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ortho Clinical Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boditech Med Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck Millipore
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMerieux
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sekisui Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tosoh Bioscience Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin S.p.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments